Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Nasdaq - Delayed Quote USD

Janus Henderson Global Life Sciences T (JAGLX)

68.73
-0.34
(-0.49%)
At close: March 28 at 8:03:44 PM EDT
Loading Chart for JAGLX
  • Previous Close 69.07
  • YTD Return 5.69%
  • Expense Ratio 0.92%
  • Category Health
  • Last Cap Gain 38.00
  • Morningstar Rating
  • Morningstar Risk Rating Above Average
  • Sustainability Rating
  • Net Assets 4.95B
  • Beta (5Y Monthly) 0.69
  • Yield 0.21%
  • 5y Average Return --
  • Holdings Turnover 35.00%
  • Last Dividend 0.15
  • Inception Date Jul 6, 2009

The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio management believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.

Janus Henderson

Fund Family

Health

Fund Category

4.95B

Net Assets

2009-07-06

Inception Date

Performance Overview: JAGLX

View More

Trailing returns as of 3/28/2025. Category is Health.

YTD Return

JAGLX
5.69%
Category
7.95%
 

1-Year Return

JAGLX
2.50%
Category
30.16%
 

3-Year Return

JAGLX
7.67%
Category
16.10%
 

5-Year Return

JAGLX
10.73%
Category
15.71%
 

People Also Watch

Holdings: JAGLX

View More

Sector Weightings

SectorJAGLX
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Recent News: JAGLX

View More

Research Reports: JAGLX

View More

Top Mutual Funds